Probing the binding site of curcumin in Escherichia coli and Bacillus subtilis FtsZ–a structural insight to unveil antibacterial activity of curcumin S Kaur, NH Modi, D Panda, N Roy European journal of medicinal chemistry 45 (9), 4209-4214, 2010 | 215 | 2010 |
The emerging role of lncRNAs in inflammatory bowel disease R Yarani, AH Mirza, S Kaur, F Pociot Experimental & molecular medicine 50 (12), 1-14, 2018 | 134 | 2018 |
Effects of GWAS-associated genetic variants on lncRNAs within IBD and T1D candidate loci AH Mirza, S Kaur, CA Brorsson, F Pociot PLoS One 9 (8), e105723, 2014 | 90 | 2014 |
Breast milk-derived extracellular vesicles enriched in exosomes from mothers with type 1 diabetes contain aberrant levels of microRNAs AH Mirza, S Kaur, LB Nielsen, J Størling, R Yarani, M Roursgaard, ... Frontiers in Immunology 10, 2543, 2019 | 87 | 2019 |
Simeprevir potently suppresses SARS-CoV-2 replication and synergizes with remdesivir HS Lo, KPY Hui, HM Lai, X He, KS Khan, S Kaur, J Huang, Z Li, ... ACS central science 7 (5), 792-802, 2021 | 80 | 2021 |
Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitus N Samandari, AH Mirza, LB Nielsen, S Kaur, P Hougaard, S Fredheim, ... Diabetologia 60, 354-363, 2017 | 73 | 2017 |
Abnormal islet sphingolipid metabolism in type 1 diabetes LJ Holm, L Krogvold, JP Hasselby, S Kaur, LA Claessens, MA Russell, ... Diabetologia 61, 1650-1661, 2018 | 68 | 2018 |
Bisnaphthalimidopropyl Derivatives as Inhibitors of Leishmania SIR2 Related Protein 1 J Tavares, A Ouaissi, P Kong Thoo Lin, I Loureiro, S Kaur, N Roy, ... ChemMedChem: Chemistry Enabling Drug Discovery 5 (1), 140-147, 2010 | 65 | 2010 |
Long non-coding RNAs as novel players in β cell function and type 1 diabetes AH Mirza, S Kaur, F Pociot Human genomics 11, 1-10, 2017 | 49 | 2017 |
Genes affecting β-cell function in type 1 diabetes T Fløyel, S Kaur, F Pociot Current diabetes reports 15, 1-11, 2015 | 46 | 2015 |
The genetic and regulatory architecture of ERBB3-type 1 diabetes susceptibility locus S Kaur, AH Mirza, CA Brorsson, T Fløyel, J Størling, HB Mortensen, ... Molecular and Cellular Endocrinology 419, 83-91, 2016 | 41 | 2016 |
miRNA-27a-3p and miRNA-222-3p as novel modulators of phosphodiesterase 3a (PDE3A) in cerebral microvascular endothelial cells S Yasmeen, S Kaur, AH Mirza, B Brodin, F Pociot, C Kruuse Molecular Neurobiology 56, 5304-5314, 2019 | 31 | 2019 |
Cell type-selective expression of circular RNAs in human pancreatic islets S Kaur, AH Mirza, F Pociot Non-coding RNA 4 (4), 38, 2018 | 27 | 2018 |
Influence of disease duration on circulating levels of miRNAs in children and adolescents with new onset type 1 diabetes N Samandari, AH Mirza, S Kaur, P Hougaard, LB Nielsen, S Fredheim, ... Non-coding RNA 4 (4), 35, 2018 | 25 | 2018 |
Genetic risk score modelling for disease progression in new-onset type 1 diabetes patients: Increased genetic load of islet-expressed and cytokine-regulated candidate genes … CA Brorsson, LB Nielsen, ML Andersen, S Kaur, R Bergholdt, L Hansen, ... Journal of diabetes research 2016, 2016 | 21 | 2016 |
Genetic predisposition in the 2′-5′ A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity K Pedersen, M Haupt-Jorgensen, L Krogvold, S Kaur, IC Gerling, F Pociot, ... Diabetologia 64 (8), 1805-1815, 2021 | 19 | 2021 |
A dual systems genetics approach identifies common genes, networks, and pathways for type 1 and 2 diabetes in human islets S Kaur, AH Mirza, AJ Overgaard, F Pociot, J Størling Frontiers in genetics 12, 630109, 2021 | 19 | 2021 |
Cytotoxicity and cell death mechanisms induced by a novel bisnaphthalimidopropyl derivative against the NCI-H460 non-small lung cancer cell line R T Lima, G A Barron, J A Grabowska, G Bermano, S Kaur, N Roy, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2013 | 18 | 2013 |
Structural analysis of trypanosomal sirtuin: an insight for selective drug design S Kaur, AV Shivange, N Roy Molecular diversity 14, 169-178, 2010 | 17 | 2010 |
Plasma exosome-enriched extracellular vesicles from lactating mothers with type 1 diabetes contain aberrant levels of miRNAs during the postpartum period C Frørup, AH Mirza, R Yarani, LB Nielsen, ER Mathiesen, P Damm, ... Frontiers in Immunology 12, 744509, 2021 | 15 | 2021 |